Jounce Therapeutics Inc (JNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,172 | 47,906 | 53,283 | 50,109 | 122,805 |
| Marketable Securities | 123,617 | 141,968 | 158,476 | 182,602 | 114,370 |
| TOTAL | $169,884 | $192,209 | $214,365 | $235,330 | $257,607 |
| Non-Current Assets | |||||
| PPE Net | 12,678 | 13,540 | 14,239 | 15,143 | 15,842 |
| Investments And Advances | 9,455 | 5,990 | 2,969 | 0 | 0 |
| Other Non-Current Assets | 21,192 | 2,713 | 2,663 | 2,682 | 2,668 |
| TOTAL | $43,325 | $22,243 | $19,871 | $17,825 | $18,510 |
| Total Assets | $213,209 | $214,452 | $234,236 | $253,155 | $276,117 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,032 | 3,272 | 2,910 | 2,990 | 5,539 |
| Accrued Expenses | 5,995 | 6,952 | 7,779 | 6,986 | 5,964 |
| Other current liabilities | 120 | 165 | 118 | 152 | 434 |
| TOTAL | $75,719 | $65,546 | $69,754 | $65,681 | $70,957 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 62,927 | 55,157 | 58,947 | 55,553 | 59,020 |
| Other Non-Current Liabilities | 19,102 | 2,062 | 2,047 | 2,032 | 2,016 |
| TOTAL | $43,066 | $44,777 | $61,072 | $78,979 | $94,874 |
| Total Liabilities | $118,785 | $110,323 | $130,826 | $144,660 | $165,831 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,972 | 32,972 | 32,701 | 32,628 | 32,483 |
| Common Shares | 33 | 33 | 33 | 33 | 32 |
| Retained earnings | -176,359 | -163,907 | -161,867 | -154,230 | -149,556 |
| Other shareholders' equity | 51 | -78 | -140 | -216 | -351 |
| TOTAL | $94,424 | $104,129 | $103,410 | $108,495 | $110,286 |
| Total Liabilities And Equity | $213,209 | $214,452 | $234,236 | $253,155 | $276,117 |